Conclusion:
Our study suggests that pretreatment tumor values derived from
contrast-enhanced CT-TA may help predict survival in patients with
resectable OOSCC. This is an exploratory study and a larger number of
patients are needed to validate the performance of the predictive model
for each subsite.